OMNIPAQUE 240 mg/mL

OMNIPAQUE 240 mg/mL is a contrast media solution used for diagnostic imaging procedures. This injection solution, containing iohexol, aids in enhancing visibility during X-rays and CT scans. Ideal for intra-articular, intrathecal, intravascular, and intra procedures, it is manufactured by GE Healthcare Inc. in the USA.

OMNIPAQUE 240 mg/mL is primarily used as a contrast agent to improve the clarity of images during diagnostic imaging. It is commonly administered for X-rays, CT scans, and other imaging procedures. The solution helps in visualizing structures within the body, making it easier for healthcare professionals to identify and assess various conditions. What is OMNIPAQUE used for? It is often utilized in procedures requiring contrast enhancement, such as angiography and myelography.

When administered, OMNIPAQUE 240 mg/mL may cause temporary discomfort or warmth at the injection site. Some individuals might experience a mild metallic taste or a sensation of warmth throughout the body. These effects are generally short-lived and subside quickly. Severe reactions are rare but can occur, and immediate medical attention should be sought if they do.

OMNIPAQUE 240 mg/mL should be handled with care to avoid contamination. It is essential to follow proper injection techniques and dispose of used vials safely. Patients with a history of allergic reactions to contrast media should inform their healthcare provider before administration. Always store the solution as per the manufacturer's guidelines to maintain its efficacy.

OMNIPAQUE 240 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to consult a healthcare professional before using this contrast agent if you are taking other medications. Additionally, patients with pre-existing kidney conditions should be monitored closely during and after administration.